Cristina Hernándo

1.3k total citations
46 papers, 414 citations indexed

About

Cristina Hernándo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Cristina Hernándo has authored 46 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 23 papers in Pulmonary and Respiratory Medicine and 23 papers in Cancer Research. Recurrent topics in Cristina Hernándo's work include Advanced Breast Cancer Therapies (20 papers), HER2/EGFR in Cancer Research (11 papers) and Cancer Treatment and Pharmacology (9 papers). Cristina Hernándo is often cited by papers focused on Advanced Breast Cancer Therapies (20 papers), HER2/EGFR in Cancer Research (11 papers) and Cancer Treatment and Pharmacology (9 papers). Cristina Hernándo collaborates with scholars based in Spain, United States and United Kingdom. Cristina Hernándo's co-authors include Begoña Bermejo, Aňa Lluch, María Teresa Martínez, Juan Miguel Cejalvo, Pîlar Eroles, Iris Garrido‐Cano, Anna Adam‐Artigues, Octavio Burgués, Ana Lameirinhas and Isabel Chirivella and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Cristina Hernándo

44 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cristina Hernándo Spain 13 196 188 178 114 72 46 414
Sheau Wen Lok Australia 8 244 1.2× 179 1.0× 144 0.8× 82 0.7× 74 1.0× 25 431
Ning Liao China 13 191 1.0× 197 1.0× 205 1.2× 110 1.0× 60 0.8× 48 449
Layka Abbasi Asbagh Belgium 7 172 0.9× 315 1.7× 143 0.8× 59 0.5× 31 0.4× 9 464
Jianguo Lai China 13 159 0.8× 303 1.6× 248 1.4× 126 1.1× 29 0.4× 42 511
Shuiping Gao China 13 229 1.2× 263 1.4× 194 1.1× 99 0.9× 31 0.4× 28 539
Lydia Usha United States 9 150 0.8× 105 0.6× 82 0.5× 68 0.6× 49 0.7× 39 296
De Zeng China 15 194 1.0× 392 2.1× 194 1.1× 127 1.1× 41 0.6× 44 617
Eun‐Kyoung Breuer United States 13 181 0.9× 309 1.6× 152 0.9× 65 0.6× 25 0.3× 17 475
Carla Strina Italy 10 242 1.2× 107 0.6× 125 0.7× 71 0.6× 40 0.6× 25 362
Marieke A. Vollebergh Netherlands 11 313 1.6× 289 1.5× 179 1.0× 91 0.8× 172 2.4× 31 504

Countries citing papers authored by Cristina Hernándo

Since Specialization
Citations

This map shows the geographic impact of Cristina Hernándo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cristina Hernándo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cristina Hernándo more than expected).

Fields of papers citing papers by Cristina Hernándo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cristina Hernándo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cristina Hernándo. The network helps show where Cristina Hernándo may publish in the future.

Co-authorship network of co-authors of Cristina Hernándo

This figure shows the co-authorship network connecting the top 25 collaborators of Cristina Hernándo. A scholar is included among the top collaborators of Cristina Hernándo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cristina Hernándo. Cristina Hernándo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lameirinhas, Ana, Iris Garrido‐Cano, Cristina Hernándo, et al.. (2025). Involvement of microRNAs-449/FASN axis in response to trastuzumab therapy in HER2-positive breast cancer. Molecular Medicine. 31(1). 116–116.
2.
Hernándo, Cristina, et al.. (2024). A Causal Inference Methodology to Support Research on Osteopenia for Breast Cancer Patients. Applied Sciences. 14(21). 9700–9700.
3.
Garrido‐Cano, Iris, Ana Lameirinhas, Octavio Burgués, et al.. (2024). MiRNA-449 family is epigenetically repressed and sensitizes to doxorubicin through ACSL4 downregulation in triple-negative breast cancer. Cell Death Discovery. 10(1). 372–372. 5 indexed citations
4.
Tormo, Eduardo, Iris Garrido‐Cano, Ana Lameirinhas, et al.. (2023). High VEGFR3 Expression Reduces Doxorubicin Efficacy in Triple-Negative Breast Cancer. International Journal of Molecular Sciences. 24(4). 3601–3601. 4 indexed citations
5.
Hernándo, Cristina, María Teresa Martínez, Octavio Burgués, et al.. (2023). Clinical Impact of New Treatment Strategies for HER2-Positive Metastatic Breast Cancer Patients with Resistance to Classical Anti-HER Therapies. Cancers. 15(18). 4522–4522. 23 indexed citations
6.
Adam‐Artigues, Anna, Jaume Forés-Martos, María Teresa Martínez, et al.. (2023). miR-146a-5p Promotes Angiogenesis and Confers Trastuzumab Resistance in HER2+ Breast Cancer. Cancers. 15(7). 2138–2138. 16 indexed citations
7.
Villacampa, Guillermo, Claudette Falato, Laia Paré, et al.. (2022). Pre-operative ribociclib plus letrozole versus chemotherapy: Health-related quality of life outcomes from the SOLTI CORALLEEN trial. European Journal of Cancer. 174. 232–242. 4 indexed citations
8.
Villacampa, Guillermo, Laia Paré, Cristina Hernándo, et al.. (2022). Abstract P4-10-04: Health-related quality of life (HRQoL) in hormone receptor-positive, HER2-negative, luminal B breast cancer patients treated with ribociclib plus letrozole or chemotherapy. Cancer Research. 82(4_Supplement). P4–10. 1 indexed citations
9.
Hernándo, Cristina, et al.. (2022). Immunological Landscape of HER-2 Positive Breast Cancer. Cancers. 14(13). 3167–3167. 7 indexed citations
10.
Pernas, Sònia, Cristina Hernándo, Begoña Bermejo, et al.. (2022). Abstract OT2-20-01: Rogaratinib, palbociclib and fulvestrant in advanced hormone receptor-positive (HR+), FGFR1/2-positive breast cancer: Phase I trial plus an expansion cohort. Cancer Research. 82(4_Supplement). OT2–20. 2 indexed citations
11.
Hernándo, Cristina, María Teresa Martínez, Pîlar Eroles, et al.. (2021). Oral Selective Estrogen Receptor Degraders (SERDs) as a Novel Breast Cancer Therapy: Present and Future from a Clinical Perspective. International Journal of Molecular Sciences. 22(15). 7812–7812. 78 indexed citations
12.
Adam‐Artigues, Anna, Iris Garrido‐Cano, Juan Antonio Carbonell‐Asins, et al.. (2021). Identification of a Two-MicroRNA Signature in Plasma as a Novel Biomarker for Very Early Diagnosis of Breast Cancer. Cancers. 13(11). 2848–2848. 20 indexed citations
13.
Liello, Raimondo Di, Begoña Bermejo, Cristina Hernándo, et al.. (2021). Fertility and breast cancer: A literature review of counseling, preservation options and outcomes. Critical Reviews in Oncology/Hematology. 166. 103461–103461. 15 indexed citations
14.
Oltra, Sara S., Juan Miguel Cejalvo, Eduardo Tormo, et al.. (2020). HDAC5 Inhibitors as a Potential Treatment in Breast Cancer Affecting Very Young Women. Cancers. 12(2). 412–412. 14 indexed citations
15.
Garrido‐Cano, Iris, Vera Constâncio, Anna Adam‐Artigues, et al.. (2020). Circulating miR-99a-5p Expression in Plasma: A Potential Biomarker for Early Diagnosis of Breast Cancer. International Journal of Molecular Sciences. 21(19). 7427–7427. 27 indexed citations
16.
Garrido‐Cano, Iris, Anna Adam‐Artigues, Eduardo Tormo, et al.. (2020). MicroRNA-33b Suppresses Epithelial–Mesenchymal Transition Repressing the MYC–EZH2 Pathway in HER2+ Breast Carcinoma. Frontiers in Oncology. 10. 1661–1661. 13 indexed citations
17.
Álvarez, Martina, Luís Vicioso, Cristina Hernándo, et al.. (2019). Detection of TP53 and PIK3CA Mutations in Circulating Tumor DNA Using Next-Generation Sequencing in the Screening Process for Early Breast Cancer Diagnosis. Journal of Clinical Medicine. 8(8). 1183–1183. 44 indexed citations
18.
Martínez, María Teresa, Begoña Bermejo, Cristina Hernándo, et al.. (2018). Breast cancer in pregnant patients: A review of the literature. European Journal of Obstetrics & Gynecology and Reproductive Biology. 230. 222–227. 18 indexed citations
19.
Costa, Marta D., Elisabet Lloveras, Elena Ordóñez, et al.. (2015). Three-Year Follow-Up of a Prenatally Ascertained Apparently Non-Mosaic sSMC(10): Delineation of a Non-Critical Region. Cytogenetic and Genome Research. 147(4). 209–211. 1 indexed citations
20.
Sanmartín, Elena, Rafael Sirera, Ana Blasco, et al.. (2013). A Gene Signature Combining the Tissue Expression of Three Angiogenic Factors is a Prognostic Marker in Early-stage Non-small Cell Lung Cancer. Annals of Surgical Oncology. 21(2). 612–620. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sheau Wen Lok Breakdown of academic impact, for papers by Ning Liao Breakdown of academic impact, for papers by Layka Abbasi Asbagh Breakdown of academic impact, for papers by Jianguo Lai Breakdown of academic impact, for papers by Shuiping Gao Breakdown of academic impact, for papers by Lydia Usha Breakdown of academic impact, for papers by De Zeng Breakdown of academic impact, for papers by Eun‐Kyoung Breuer Breakdown of academic impact, for papers by Carla Strina Breakdown of academic impact, for papers by Marieke A. Vollebergh
Rankless by CCL
2026